EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Development and Assessment of Interstitial Brachytherapy Using Individual Curved-Needle in Treatment of Recurrent Gynecological Tumors After External Beam Radiotherapy

Yining Chen, Zheng Zeng, Jie Zhang, Chunli Luo, Lang Yu, Yuliang Sun, Bing Zhou, Lihua Yu, Junfang Yan iD, Ke Hu iD, Fuquan Zhang

Technology in Cancer Research & Treatment · 2026-07 · 25

DOI: 10.1177/15330338261470898 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 21.07.2026. Verfasst von Yining Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing,…. Hauptthemen laut MEDLINE: Brachytherapy, Neoplasm Recurrence, Local, Genital Neoplasms, Female. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National High Level Hospital Clinical Research Funding, National Key R&D Program of China, Ministry of Science and Technology of the People’s Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

To evaluate the efficacy and safety of individualized curved-needle interstitial brachytherapy (ISBT) using 3D printing for recurrent gynecologic tumors.

Method

This retrospective observational study enrolled patients with pelvic recurrent gynecologic tumors from March 2022 to April 2024. All patients received external beam radiotherapy (EBRT) (40–60 Gy, 20–30 fractions), followed by individualized curved-needle ISBT using a 3D-printed applicator (12–30 Gy, 2–5 fractions). Concurrent systemic therapy was administered when necessary. Dosimetric parameters (V100%, V200%, D100%, D98%, D90%, D50%, D5cc, D2cc, D0.1cc) were assessed. Clinical outcomes and treatment-related complications were analyzed.

Results

A total of 13 patients were included, including 4 patients with prior radiation therapy and 9 without prior radiation therapy; 45 fractions of ISBT were analyzed. Central and non-central pelvic recurrences occurred in 46.2% and 53.8% of patients, respectively. Eight patients received concurrent systemic therapy. The cumulative equivalent dose in 2-Gy fractions (EQD2) to the clinical target volume of recurrence treatment was 64.87 ± 7.16 Gy for patients with prior radiation and 73.03 ± 9.95 Gy for those without prior radiation. The corresponding cumulative EQD2 to the D2cc of the bladder, rectum, and sigmoid colon were 63.98 ± 11.37 Gy vs. 79.00 ± 12.34 Gy, 61.93 ± 8.90 Gy vs. 68.44 ± 9.93 Gy, and 41.22 ± 20.79 Gy vs. 54.49 ± 7.45 Gy, respectively. At a median follow-up of 38 months, 92.3% (12/13) of patients were alive. The 2-year and 3-year local control rates were 92.3% and 82.1%, respectively. Acute Grade 3 toxicity was observed in 30.8%, and late Grade 3 toxicity in 7.7%.

Conclusion

Individualized curved-needle ISBT with a 3D-printed applicator provided high-quality treatment for recurrent gynecologic tumors with favorable outcomes and acceptable toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyNeoplasm Recurrence, LocalGenital Neoplasms, FemaleHumansFemaleMiddle AgedRetrospective StudiesAgedAdultNeedlesTreatment OutcomeRadiotherapy DosagePrinting, Three-DimensionalRadiotherapy Planning, Computer-Assisted

Stichwörter der Autor:innen

clinical outcomesindividual curved-needlesinterstitial brachytherapyrecurrent gynecological tumortoxicity

Autor:innen und Institutionen

  • Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Department of Radiation Oncology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.

ORCID-Profile: Junfang Yan, Ke Hu

Förderung

  • National High Level Hospital Clinical Research Funding
  • National Key R&D Program of China, Ministry of Science and Technology of the People’s Republic of China

Zitieren

APA

Chen, Y., Zeng, Z., Zhang, J., Luo, C., Yu, L., Sun, Y., Zhou, B., Yu, L., Yan, J., Hu, K., & Zhang, F. (2026). Development and Assessment of Interstitial Brachytherapy Using Individual Curved-Needle in Treatment of Recurrent Gynecological Tumors After External Beam Radiotherapy. Technology in Cancer Research & Treatment, 25. https://doi.org/10.1177/15330338261470898

Vancouver

Chen Y, Zeng Z, Zhang J, Luo C, Yu L, Sun Y, et al. Development and Assessment of Interstitial Brachytherapy Using Individual Curved-Needle in Treatment of Recurrent Gynecological Tumors After External Beam Radiotherapy. Technology in Cancer Research & Treatment. 2026;25. doi:10.1177/15330338261470898

BibTeX
@article{Chen2026,
  author = {Chen, Yining and Zeng, Zheng and Zhang, Jie and Luo, Chunli and Yu, Lang and Sun, Yuliang and Zhou, Bing and Yu, Lihua and Yan, Junfang and Hu, Ke and Zhang, Fuquan},
  title = {Development and Assessment of Interstitial Brachytherapy Using Individual Curved-Needle in Treatment of Recurrent Gynecological Tumors After External Beam Radiotherapy},
  journal = {Technology in Cancer Research & Treatment},
  year = {2026},
  volume = {25},
  doi = {10.1177/15330338261470898}
}
Kostenlos starten →